eXoZymes, Inc. (EXOZ) Stock

Healthcare · Biotechnology · Member of Other US Stocks

eXoZymes, Inc. (EXOZ) closed at USD 4.60 on 2026-10-14, a change of -62.8 % over the past year, with a market capitalization of USD 37.22M.

eXoZymes, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

eXoZymes, Inc. key figures

Previous close

USD 4.60 (2026-10-14)

1-year change

-62.8 %

Market cap

USD 37.22M

Enterprise value

USD 32.56M

P/E ratio (trailing)

-3.85

P/E ratio (forward)

n/a

EPS (trailing)

-1.04

EPS (forward)

n/a

PEG ratio

n/a

Price to book

10.15

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

2.43

Employees

32

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About eXoZymes, Inc.

eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for eXoZymes, Inc. and compare it with other stocks.